Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > ARZ

<< Previous

Bullboard Posts

Next >>

Comment by Fastlane2on Dec 15, 2012 6:59am

340 Views

Post# 20734844

RE: RE: RE: RE: ARZ

"True that Aurizon has a reputation for conservatism"
Read more at https://www.stockhouse.com/bullboards/messagedetail.aspx?s=NOX&t=LIST&m=31914275&l=0&pd=1&r=0#35QYVtmpqg4r71wz.99

Isn't that the truth about Aurizon.

Mr.Monk your story line is bang on and anybody who has been following the joint venture knows that. It would be nice to see continued progress with the next phase and continue the drilling. I would be surprised if Aurizon walked away from this venture as the hawks would be circling if they did, but as you stated, it's their conservatism that makes you question why not proceed and grow your company. GL.

Fastlane

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features